2-32141905-C-T

Variant summary

Our verdict is Pathogenic. The variant received 23 ACMG points: 23P and 0B. PS3PM1PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_014946.4(SPAST):​c.1495C>T​(p.Arg499Cys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 14/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000645351: Experimental studies have shown that this missense change affects SPAST function (PMID:15716377).; SCV002556973: PS3; SCV006583854: "Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product." PMID:15716377; SCV000617691: Published functional studies demonstrate a damaging effect on microtubule disassembly and ATPase activity (Errico et al., 2002; Evans et al., 2005); SCV005622624: Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID:15716377)". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R499H) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SPAST
NM_014946.4 missense, splice_region

Scores

17
1
Splicing: ADA: 0.9223
1
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:14O:1

Conservation

PhyloP100: 2.52

Publications

16 publications found
Variant links:
Genes affected
SPAST (HGNC:11233): (spastin) This gene encodes a member of the AAA (ATPases associated with a variety of cellular activities) protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The use of alternative translational initiation sites in this gene results in a single transcript variant that can produce isoforms that differ in the length of their N-terminus and which thereby differ in the efficiency of their export from the nucleus to the cytoplasm. In addition, alternative splicing results in multiple transcript variants that encode isoforms that differ in other protein regions as well. One isoform of this gene has been shown to be a microtubule-severing enzyme that regulates microtubule abundance, mobility, and plus-end distribution. Mutations in this gene cause the most frequent form of autosomal dominant spastic paraplegia 4. [provided by RefSeq, May 2018]
SPAST Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 4
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Orphanet
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • SPAST-related motor disorder
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 23 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000645351: Experimental studies have shown that this missense change affects SPAST function (PMID: 15716377).; SCV002556973: PS3; SCV006583854: "Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product." PMID: 15716377; SCV000617691: Published functional studies demonstrate a damaging effect on microtubule disassembly and ATPase activity (Errico et al., 2002; Evans et al., 2005); SCV005622624: Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 15716377)
PM1
In a hotspot region, there are 15 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 10 uncertain in NM_014946.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-32141906-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 240950.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 148 curated pathogenic missense variants (we use a threshold of 10). The gene has 21 curated benign missense variants. Gene score misZ: 1.2438 (below the threshold of 3.09). Trascript score misZ: 0.22274 (below the threshold of 3.09). GenCC associations: The gene is linked to hereditary spastic paraplegia 4, SPAST-related motor disorder, neurodevelopmental disorder, Charlevoix-Saguenay spastic ataxia.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.989
PP5
Variant 2-32141905-C-T is Pathogenic according to our data. Variant chr2-32141905-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 5660.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014946.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPAST
NM_014946.4
MANE Select
c.1495C>Tp.Arg499Cys
missense splice_region
Exon 13 of 17NP_055761.2
SPAST
NM_001363823.2
c.1492C>Tp.Arg498Cys
missense splice_region
Exon 13 of 17NP_001350752.1A0A2U3TZR0
SPAST
NM_199436.2
c.1399C>Tp.Arg467Cys
missense splice_region
Exon 12 of 16NP_955468.1E5KRP6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPAST
ENST00000315285.9
TSL:1 MANE Select
c.1495C>Tp.Arg499Cys
missense splice_region
Exon 13 of 17ENSP00000320885.3Q9UBP0-1
SPAST
ENST00000621856.2
TSL:1
c.1492C>Tp.Arg498Cys
missense splice_region
Exon 13 of 17ENSP00000482496.2A0A2U3TZR0
SPAST
ENST00000713716.1
c.1600C>Tp.Arg534Cys
missense splice_region
Exon 14 of 18ENSP00000519019.1A0AAQ5BGQ0

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
248882
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1456098
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
724372
African (AFR)
AF:
0.00
AC:
0
AN:
33244
American (AMR)
AF:
0.00
AC:
0
AN:
44368
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26024
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39524
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53094
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5524
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1108978
Other (OTH)
AF:
0.00
AC:
0
AN:
60086
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000428
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
9
-
-
Hereditary spastic paraplegia 4 (10)
3
-
-
not provided (3)
1
-
-
Hereditary spastic paraplegia (1)
1
-
-
Spastic paraparesis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.97
D
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Pathogenic
0.59
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.3
H
PhyloP100
2.5
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-7.9
D
REVEL
Pathogenic
0.94
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.90
MutPred
0.96
Loss of MoRF binding (P = 0.0082)
MVP
0.99
MPC
2.6
ClinPred
1.0
D
GERP RS
5.0
Varity_R
0.97
gMVP
0.99
Mutation Taster
=7/93
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.92
dbscSNV1_RF
Pathogenic
0.75
Splicevardb
2.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908511; hg19: chr2-32366974; COSMIC: COSV59512800; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.